• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » A Primer on Transgender Care

A Primer on Transgender Care

April 1, 2012
Dan Karasic, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Dan Karasic, MD Clinical professor of health sciences, Department of Psychiatry, University of California, San Francisco Dr. Karasic has disclosed that he has no relevant relationships or financial interests in any commercial companies pertaining to this educational activity.

Most psychiatrists have not been specifically trained in treating transgender patients. This is a problem, because as society has become more accepting of sexual and gender diversity, more of your patients are likely to divulge to you their transgender identity. In this article I will discuss transgender care and how you can respond to the unique needs of transgender patients in your practice.

Let’s start with some definitions. “Transgender” is a general term, referring to individuals or behaviors that vary from the gender conventions of one’s culture. Older clinical terms include “transexualism,” introduced in DSM-III, and “gender identity disorder” (GID), which is found in DSM-III-R and DSM-IV. GID has been an unpopular label among patients and professionals alike, because it labels as a “disorder” something that people perceive as being intrinsic to their identity. A person’s subjective gender identity, regardless of the sex they were assigned at birth, can lie anywhere on a gender spectrum. Sometimes, people experience distress or discomfort due to a discrepancy between their gender identity and birth gender. We refer to this as “gender dysphoria,” the term that will replace GID in DSM-5.

Gender dysphoria may be related to discomfort with one’s physical body, one’s social role (and societal expectations), or both. So it’s a very broad term. We should be careful not to confuse it with “gender nonconformity,” which simply means that a person expresses one’s gender in a manner different from what’s conventional. We use this term, for instance, to refer to boys who prefer girls’ play or girls’ dress, or vice versa. Gender non-conformity is, in itself, not pathological, and does not presuppose that a person experiences distress. If a child exhibits distress, it’s usually due to bullying or rejection by a family member or acquaintance. A national organization called Gender Spectrum works with parents and families of gender-nonconforming children to try to improve their experience (www.genderspectrum.org). In adults, distress often arises from the effects of stigma, marginalization, or discrimination.

Assessment and Treatment of the Transgender Individual
Individuals with gender dysphoria may present to your office with a range of mental health concerns. These concerns—such as anxiety, depression, self-harm, personality disorders, substance abuse, and eating disorders—often are addressed concurrently with steps to relieve gender dysphoria. Psychotherapy, while not a requirement for hormonal or surgical treatments, can be helpful to explore gender identity, to assist the patients in making informed decisions about further treatment, to improve self-esteem, or to build a support network. According to the World Professional Association for Transgender Health (WPATH) standards of care, it is no longer considered ethical to try to change a person’s gender identity or expression in order to be more congruent with one’s birth sex.

Gender Transition
Patients with persistent gender dysphoria may choose to undergo “gender transition,” the process of making social role and the body more congruent with gender identity. (The old term for this process was “sex change.”) This process may include social transition, hormonal therapy, and for some, surgery.

Social transition means living in the gender role that the person wants to live in. For someone born male but wanting to transition to female, this would mean living as female, dressing as female, changing one’s name, presenting at work as female, and coming out to friends as transgender.

Hormonal therapy. Some individuals are comfortable with a social transition, and if so, treatment ceases here. Others may proceed to hormonal therapy. In children at Tanner Stage 2 (very early puberty), we may offer gonadotropin-releasing hormone (GnRH) analogs like Lupron to delay the onset of puberty. This is a reversible procedure, but the delay allows more time for the child and therapist to confirm the persistence of gender dysphoria and prepare the patient for possible further hormonal or surgical treatment.

In adults, the goals of hormonal therapy are to reduce endogenous hormones and provide hormones of the reassigned sex. Regimens for those who are male-to-female (MTF) transgender include estradiol and antiandrogens like spironolactone. Female-to-male (FTM) patients typically receive testosterone, either injection, patch or gel (Hembree WC et al, J Clin Endocrinol Metab 2009;94(9):3132–3154).

Hormonal therapy is generally safe, but risks are not trivial and require monitoring. MTF patients should be screened for thromboembolic disease and elevated triglycerides, as well as hypertension and coronary artery disease, since hormonal treatments can cause or exacerbate these conditions. Testosterone replacement in FTM patients can cause polycythemia, which may lead to myocardial infarction or stroke. Psychotic or manic symptoms induced by testosterone are rare but can be seen with supraphysiologic blood levels of androgens. Be aware that some patients obtain hormones via the Internet or from abroad, so taking a careful history is necessary.

Transition surgery. Many MTF patients opt for breast construction surgery and facial feminization surgery, while FTM patients often undergo mastectomy. Most transgender people in the United States—whether male or female—do not have genital surgery. Genital surgery is expensive and difficult to access, and some FTM patients, in particular, find options for phalloplasty unsatisfactory. Moreover, most health insurance plans specifically exclude all transgender surgeries, although allowances are sometimes made for procedures deemed “medically necessary” by therapists. In the past, the US government required that people have surgery to change their gender on legal documents (eg, for passports), but this requirement has been dropped.

An excellent, and easily accessible, resource for anyone interested in the comprehensive care of transgender persons is the WPATH Standards Of Care Version 7 document, available for free online (bit.ly/nwkQV5).

Specific Treatment Concerns
While many transgender adults are mentally healthy, studies show that they suffer high rates of depression and other health concerns. The available data show rates of depression approaching 50% (Bockting WO et al, Int J Transgender 2005;8(2):123–131), and rates of lifetime suicidal ideation ranging from 37% to 52% (The Health of Lesbian, Gay, Bisexual, and Transgender People; Institute of Medicine 2011; bit.ly/yKzbEd). Rates of HIV infection are as high as 28% among MTF transgender women, and many MTFs report engagement in risky sex behaviors (Herbst JH et al, AIDS Behav 2008;12(1):1–17).

One’s gender identity is also independent of one’s sexual orientation, so a transgender identity should not be equated with either homosexuality or heterosexuality. There are many MTF transgender people who are attracted to women, and FTM transgender people attracted to men. We do sometimes see the objects of one’s sexual attraction change after transition; for example, a female-to-male patient who defined herself as a lesbian before transition may become attracted to men and identify as a gay man afterward.

DSM-5 Proposed Revisions to Gender Dysphoria (formerly Gender Identity Disorder)


A marked incongruence between one’s experienced/expressed gender and assigned gender lasting at least six months that causes significant distress or impairment in social and work relationships, and includes two or more of the following factors:

  1. A conflict between one’s experienced/expressed gender and primary and/or secondary sex characteristics

  2. A strong desire not to have one’s primary and/or secondary sex characteristics because of the conflict with one’s experienced/expressed gender

  3. A strong desire for the primary and/or secondary sex characteristics of the other gender

  4. A strong desire to be of the opposite gender or an alternative gender

  5. A strong desire to be treated as the opposite gender or an alternative gender

  6. A belief that one’s feeling and reactions are those of the opposite gender or an alternative gender


The DSM-5 revisions include a “post transition” specifier related to transgender individuals who have undergone either some hormonal or surgical treatment.

Source: www.dsm5.org


TCPR Verdict:
As people become more comfortable discussing gender identity, transgender patients and others with gender dysphoria may seek your care. Their specific needs may include exploring gender identity and expression, facilitating a coming out process, or an assessment for a medical intervention. It’s important that you not try to impose any particular conception or belief, but instead help them to achieve lasting comfort in their gender identity expression, and to identify the resources with which to do so.
General Psychiatry
KEYWORDS gender_
    Dan Karasic, MD

    More from this author
    www.thecarlatreport.com
    Issue Date: April 1, 2012
    SUBSCRIBE NOW
    Table Of Contents
    Sexual and Gender Diversity: Practice Tips
    A Primer on Transgender Care
    The Struggles of ‘Coming Out’
    Thyroid Function
    Depression
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.